Table 1.
Patient characteristics (n = 262)
| Gender (% male/% female) | 26/74 | |
| Age in years (mean, (SD)) | 47.6 (11.7) | Range 21.1–79.9 |
| Disease duration in years (mean, (SD)) | 8.6 (7.9) | Range 0.1–53.7 |
| Disease course (% RR, % SP, % PP) | 52/26/22 | |
| EDSS (mean, (SD)) | 4.0 (2.2) | Range 0–8 |
| HADS-depression (% <8/% ≥8) | 68/32 | |
| Use of disease modifying drugs (% yes, % no) | 43.5/56.5 | |
| Interferon (%) | 18.3 | |
| Glatiramer acetate (%) | 3.8 | |
| Other (%) | 15.3 | |
| Use of psychopharmaca (% yes, % no) | 26/74 | |
| Level of education (% low, % average, % high) | 28/36/36 | |
| Marital status (% partner/% no partner) | 78/22 | |
| Employment status (% working, % not working) | 30/70 |
RR Relapsing Remitting, SP Secondary Progressive, PP Primary Progressive, EDSS Expanded Disability Status Scale, HADS Hospital Anxiety and Depression Scale